If there was a way to catch Alzheimer's earlier, to see its onset in the most nascent of stages, medical researchers postulate that would allow patients to access novel treatments earlier than ever before. At the University of Minnesota's Center for Drug Design (CDD), researchers are working towards that goal. First, however, the must surmount the problem of early detection. Read the article by John Tolley (and watch the video)